Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

transcreation

- PMLiVE

Beyond the hype: the future of AI in pharmaceutical marketing

By Brian Norman

Helping Patients Become Active Participants in Their Own Care

Rishi Nayyar, Co-founder & CEO of PocketHealth, explores how releasing medical imaging records straight to patients can result in data moving more ethically, easily, and securely. He also shares his...

Impetus Digital

- PMLiVE

AbbVie’s Rinvoq approved by EC for Crohn’s disease

The therapy is now the first oral JAK inhibitor authorised to treat this patient population

- PMLiVE

Eli Lilly to invest additional $1.6bn in US manufacturing sites

The company will also be adding another 200 highly skilled jobs at the new facilities

- PMLiVE

NHS spring COVID-19 booster programme opens up for those at highest risk

Around five million people are eligible for the booster in line with the JCVI’s advice

- PMLiVE

The importance of AI in improving patient care

Looking at the ways healthcare technology creates the capacity to improve collaboration, increase efficiency and optimise patient care

- PMLiVE

Medscape Education Global Delivers Education and Outcomes to ECCMID 2023

Medscape Education Global has wrapped up its time in Copenhagen at ECCMID 2023. During the conference, Medscape Education Global had the opportunity to engage learners with an educational symposium and...

Medscape Education

Antithrombotic Therapy for Peripheral Artery Disease: Medscape Education and Outcomes

At this year’s ACC2023 event, the Medscape Education team shared 7 posters highlighting the outcomes of cardiology continuing medical education (CME) programs. These posters covered a variety of cardiology topics...

Medscape Education

- PMLiVE

GSK to acquire Bellus Health for approximately $2bn

The deal includes the biotech’s late-stage candidate for refractory chronic cough

- PMLiVE

FDA approves Gamida’s cell therapy for blood cancer patients

Blood cancers represent about 10% of all annual US cancer cases

- PMLiVE

Authorisation for Moderna and Pfizer/BioNTech’s bivalent COVID-19 vaccines simplified by FDA

The vaccines are now authorised for all doses in individuals aged six months and older

- PMLiVE

Tiziana to develop intranasal foralumab for type 1 diabetes

Approximately 4.7 million people in the UK are currently living with diabetes

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links